EU approves Alexion’s Koselugo for plexiform neurofibromas in adults with neurofibromatosis type 1: Cambridge, UK Wednesday, October 29, 2025, 11:00 Hrs [IST] Alexion, AstraZene ...
New relacorilant data presented at ESMO demonstrated a consistent benefit in PARPi subgroups to overcome chemotherapy resistance. Relacorilant plus nab-paclitaxel showed a PFS benefit in patients with ...
Novartis has started to feel the squeeze from generics to its top-selling drug, heart therapy Entresto. | Novartis has ...
The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback